Newleos Therapeutics
PrivateLast Round
Series A
Feb 13, 2025
Total Funding Raised
$93.5M
Momentum Score
50 /100
Company Overview
Newleos Therapeutics is a clinical-stage biotechnology company that develops therapies for mental illnesses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
neuropsychiatric therapeuticsoral small moleculesclinical-stage biotechgeneralized anxiety disorderGADanxiolyticsnon-sedating anxiolyticsCNS drug developmentpositive allosteric modulatorPAMsubstance use disordersSUDsasset in-licensingsocial anxiety disorderSADcognitive impairmentV1a receptor antagonistTAAR1 partial agonist
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Newleos Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Newleos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 13, 2025 |
Key People
Founding team and executive leadership
Newleos Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCVC Bio | Series A |
| Novo Holdings | Series A |
| Arkin Bio Capital | Series A |
| Longwood Fund | Series A |
| Goldman Sachs Alternatives | Series A |
Newleos Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Newleos Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersBoston, Massachusetts
Employee Range26
Year Founded2024
Last FundingFeb 13, 2025
